Massachusetts Selects Appriss' PMP Solutions to Enhance Interoperability
February 01, 2016 12:09 ET
|
Appriss
LOUISVILLE, Ky., Feb. 1, 2016 (GLOBE NEWSWIRE) -- Appriss Inc., a leading technology provider for risk assessment and analytics in public safety, retail and healthcare, announced that it has signed an...
Vermont Adopts Appriss' Platform to Mitigate Drug Diversion
January 11, 2016 11:05 ET
|
Appriss
LOUISVILLE, Ky., Jan. 11, 2016 (GLOBE NEWSWIRE) -- Appriss Inc., a leading technology provider for risk assessment and analytics in public safety and healthcare, announced that the state of Vermont...
Kroger Introduces Appriss' NARxCHECK(TM) into Pharmacies
August 12, 2015 11:51 ET
|
Appriss
LOUISVILLE, Ky., Aug. 12, 2015 (GLOBE NEWSWIRE) -- Appriss Inc., a leading technology provider for risk assessment and analytics in public safety and healthcare, announced that The Kroger Co. has...
Cerner Integrates NARxCHECK(TM) Into Electronic Health Record System
August 06, 2015 10:30 ET
|
Appriss
LOUISVILLE, Ky., Aug. 6, 2015 (GLOBE NEWSWIRE) -- Appriss Inc., a leading technology provider for risk assessment and analytics in public safety and health care, announced that Cerner (Nasdaq: CERN),...
NEXAFED(TM) Pseudoephedrine Tablets Disrupt Methamphetamine Production
March 02, 2012 06:30 ET
|
Acura Pharmaceuticals
PALATINE, IL--(Marketwire - Mar 2, 2012) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced independent laboratory...
Acura Pharmaceuticals Provides Update on Opioid Product Licensed to Pfizer
October 17, 2011 06:00 ET
|
Acura Pharmaceuticals
PALATINE, IL--(Marketwire - Oct 17, 2011) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company, announced that they have been informed by Pfizer, Inc. (NYSE: PFE) that...